Liquidia Corporation Common Stock vs Petróleo Brasileiro SA — how do they compare? Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B), while Petróleo Brasileiro SA trades at $25.79 (market cap $159.16B). The key difference: Petróleo Brasileiro SA is far larger — about 52.4× Liquidia Corporation Common Stock's market cap, and Petróleo Brasileiro SA pays a 6.46% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Petróleo Brasileiro SA for 26 Days on average.
| LQDA | PBR | |
|---|---|---|
Market Cap | $3.04B | $159.16B |
Volume | 21,111,778 | 19,717,211 |
Sector | Health | Energy |
52-Week High | $91.03 | $25.94 |
52-Week Low | $22.02 | $11.54 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $2.94B | $219.58B |
Dividend Yield | — | 6.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Petrobras (PBR) trades at $25.50, up 0.31% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with a P/E of 6.55, net income margin of 24.52%, and Q2 2026 earnings beat. Recent developments include new oil discoveries and LNG supply agreements, supporting growth prospects. Analyst consensus is bullish with 50% buy ratings, though the current price exceeds the $22.33 consensus target.
PBR offers attractive valuation metrics and strong profitability, but faces execution risks from capital-intensive projects and political exposure. The stock's technical overbought condition near resistance levels suggests potential near-term consolidation. Long-term growth drivers include production expansion and strategic partnerships, though investors should monitor debt levels and Brazilian regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →